UBS lowered the firm’s price target on Molina Healthcare (MOH) to $170 from $180 and keeps a Neutral rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target lowered to $180 from $210 at Cantor Fitzgerald
- Molina Healthcare price target lowered to $167 from $207 at Goldman Sachs
- Molina Healthcare price target lowered to $165 from $203 at Deutsche Bank
- Molina Healthcare downgraded to Underweight from Equal Weight at Barclays
- Molina Healthcare’s Q3 2025 Financial Performance Overview